FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

3638711000001107: Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25813101000001110 Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
68682901000001114 Neo-Naclex-K modified-release tablets (Mercury Pharma Group Ltd) 100 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Is a Bendroflumethiazide 2.5mg / Potassium 8.4mmol modified-release tablets 100 tablet true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Is pack of Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) false Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Has active ingredient Potassium chloride false Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Has active ingredient Potassium false Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Has active ingredient Bendroflumethiazide false Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Has active ingredient Bendrofluazide - chemical false Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Has AMP Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Has specific active ingredient Potassium chloride true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Has specific active ingredient Bendroflumethiazide true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start